SCHEMBL13048622

SCHEMBL13048622

COc1cc(Nc2nc(NC3CC3)c3c(S(C)(=O)=O)n[nH]c3n2)cc(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 2/20 0.44
ULK2 Q8IYT8 2/20 0.44
IGF1R P08069 4/20 0.42
MERTK Q12866 4/20 0.41
PDGFRA P16234 3/20 0.40
CCNE1 P24864 3/20 0.40
CDK2 P24941 3/20 0.40
TYRO3 Q06418 4/20 0.38
FLT3 P36888 2/20 0.38
GAS6 Q14393 2/20 0.38
AXL P30530 2/20 0.38
SYK P43405 4/20 0.38
MEN1 O00255 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13048601 0.90 MERTK (0.53) ULK1ULK2IGF1RMERTKTYRO3
SCHEMBL13048739 0.88 PTK2 (0.42) ULK1ULK2IGF1RPDGFRAFLT3
SCHEMBL13048126 0.85 ULK1 (0.53) ULK1ULK2MERTKTYRO3FLT3
SCHEMBL13048722 0.82 MERTK (0.47) IGF1RMERTKTYRO3FLT3GAS6
SCHEMBL13048626 0.81 SYK (0.45) MERTKTYRO3FLT3SYKPIK3CD
SCHEMBL13048598 0.81 SYK (0.52) MERTKFLT3AXLSYKPIK3CD
SCHEMBL13048641 0.81 SYK (0.45) MERTKTYRO3FLT3GAS6AXL
SCHEMBL13048648 0.80 PIK3CD (0.43) PDGFRACCNE1CDK2TYRO3SYK
SCHEMBL13048627 0.80 PIK3CD (0.41) CDK2TYRO3SYKPIK3CDPIK3CA
SCHEMBL13048827 0.80 SYK (0.43) IGF1RMERTKCDK2TYRO3FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND SYK, LCK, FYN ULK1 851/4885ULK2 434/4885IGF1R 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.